Loading...
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
BACKGROUND: FOLFIRINOX is a standard treatment for metastatic pancreatic cancer patients. The effectiveness of neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer (BRPC) remains debated. METHODS: We performed a systematic review and patient-level meta-analysis on neoadjuv...
Na minha lista:
| Udgivet i: | J Natl Cancer Inst |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6695305/ https://ncbi.nlm.nih.gov/pubmed/31086963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djz073 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|